Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D03SGR
|
|||
| Former ID |
DAP001095
|
|||
| Drug Name |
Efalizumab
|
|||
| Synonyms |
Raptiva; Raptiva (TN); Efalizumab (USAN/INN)
Click to Show/Hide
|
|||
| Drug Type |
Antibody
|
|||
| Indication | Psoriasis vulgaris [ICD-11: EA90; ICD-9: 696] | Approved | [1], [2] | |
| Renal transplantation [ICD-11: NE84; ICD-10: D89.8; ICD-9: 279.5] | Phase 2 | [1], [2] | ||
| Therapeutic Class |
Immunomodulatory Agents
|
|||
| Company |
Roche
|
|||
| PubChem Substance ID | ||||
| SuperDrug ATC ID |
L04AA21
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6593). | |||
| REF 2 | New developments in immunosuppressive therapy for heart transplantation. Expert Opin Emerg Drugs. 2009 Mar;14(1):1-21. | |||
| REF 3 | [Successful therapy of discoid lupus erythematosus with efalizumab]. Hautarzt. 2010 Mar;61(3):246-9. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.